Lets see if I understand this correctly. It was stated in the interview that RECAF is only found on cancerous and malignant tumors. In the May 16th press release, Moro states the following. "So far, in all of our studies on different cancers, we have compared the average amount of RECAF in the blood of different groups of individuals (e.g. normal donors, patients with benign tumors, or cancer patients), but the normal amount of RECAF -- or any other protein in blood -- varies from one individual to another. Therefore, a range of values is used to determine if a person has a cancer. This means that the RECAF value we use to determine if a person has cancer must necessarily be high in order to avoid informing a healthy individual that he has cancer, when he may just be at the upper end of the RECAF normal spectrum. But, if we did sequential blood tests on each person and assuming their RECAF value is rather constant over time, then a small change in the level of circulating RECAF would detect cancer at the earliest stages. We do not know yet if the normal RECAF concentration is constant enough to make this personalization possible. However, if it was consistent, this suggested approach might prove to be a winning strategy in the fight against cancer. We could then have an exquisitely sensitive tool to detect many types of cancer. "
Therefore for those to be correct statements, normal people must have a significant amount of cancer cells all the time. I know that most cancer cells are attacked by the T cells and eliminated. When the T cells get overwhelmed, then you have "cancer". Is that a correct analysis?
News 
Market Data 
Discover 
